Evidence map›Paper›PMID 41276625›Full record

ArticleNPJ digital medicine2025

Domain-adaptive semi-supervised learning for efficient rare pathological lesion detection with minimal annotation.

Isao Matsui, Ayumi Matsumoto, Atsuhiro Imai, Hiroki Okushima, Hirohiko Niioka, Masatoshi Abe, Natsune Tamai, Hajime Nagasu, Eiichiro Kanda, Eiichiro Uchino and 51 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

61 authors.

Isao Matsui *Department of Nephrology, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan. matsui@kid.med.osaka-u.ac.jp.
Ayumi Matsumoto *Department of Nephrology, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
Atsuhiro ImaiDepartment of Nephrology, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
Hiroki OkushimaDepartment of Nephrology, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
Hirohiko NiiokaData-Driven Innovation Initiative, Kyushu University, Higashi-ku, Fukuoka, Japan.
Masatoshi AbeDepartment of Nephrology, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
Natsune TamaiDepartment of Nephrology, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
Hajime NagasuSubcommittee of AI/ICT Infrastructure Construction, Japanese Society of Nephrology, Bunkyo-ku, Tokyo, Japan.
Eiichiro KandaSubcommittee of AI/ICT Infrastructure Construction, Japanese Society of Nephrology, Bunkyo-ku, Tokyo, Japan.
Eiichiro UchinoSubcommittee of AI/ICT Infrastructure Construction, Japanese Society of Nephrology, Bunkyo-ku, Tokyo, Japan.
Tadashi SofueSubcommittee of AI/ICT Infrastructure Construction, Japanese Society of Nephrology, Bunkyo-ku, Tokyo, Japan.
Toshiyuki ImasawaSubcommittee of AI/ICT Infrastructure Construction, Japanese Society of Nephrology, Bunkyo-ku, Tokyo, Japan.
Yuichiro YanoSubcommittee of AI/ICT Infrastructure Construction, Japanese Society of Nephrology, Bunkyo-ku, Tokyo, Japan.
Hiroshi KinashiDepartment of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Aichi, Japan.
Ken-Ichi MiyoshiDepartment of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
Tamaki HaradaDepartment of Nephrology, Higashiosaka City Medical Center, Higashiosaka, Osaka, Japan.
Yasuyuki NagasawaDepartment of General Internal Medicine, Hyogo medical University, Nishinomiya, Hyogo, Japan.
Keiji FujimotoDepartment of Nephrology, Kanazawa Medical University School of Medicine, Kahoku, Ishikawa, Japan.
Yuka KurokawaDivision of Nephrology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Sawako KatoDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Ryohei KasedaDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Niigata, Japan.
Masahiro KoizumiDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Yasuo KusunokiDepartment of Nephrology, Toyonaka Municipal Hospital, Toyonaka, Osaka, Japan.
Masaki OhyaDepartment of Nephrology, Kindai University Nara Hospital, Ikoma, Nara, Japan.
Yoshimasa KawazoeArtificial Intelligence and Digital Twin in Healthcare, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Hiroyuki AbeDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Yuta MatsukumaDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takaaki KosugiDepartment of Nephrology, Nara Medical University, Kashihara, Nara, Japan.
Yoshiyasu UedaDepartment of Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan.
Naohiko FujiiDepartment of Nephrology, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Hyogo, Japan.
Masanobu TakejiDepartment of Nephrology, Toyonaka Municipal Hospital, Toyonaka, Osaka, Japan.
Akira SuzukiDepartment of Internal Medicine, Japan Community Health Care Organization Osaka Hospital, Osaka, Osaka, Japan.
Katsuyuki NagatoyaDepartment of Nephrology, Osaka Rosai Hospital, Sakai, Osaka, Japan.
Kazumasa OkaDepartment of Pathology, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Hyogo, Japan.
Yutaka AndoDepartment of Nephrology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan.
Masaaki IzumiDivision of Kidney and Dialysis, Department of Internal Medicine, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan.
Toshiyuki KomiyaDepartment of Nephrology, Japanese Red Cross Otsu Hospital, Otsu, Shiga, Japan.
Tatsuo TsukamotoDepartment of Nephrology and Dialysis, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Osaka, Osaka, Japan.
Imari MimuraDivision of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Takahiro KuraganoDivision of Kidney, Dialysis and Cardiology, Department of Internal Medicine, Hyogo medical University, Nishinomiya, Hyogo, Japan.
Toshiaki NakanoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kazuhiko TsuruyaDepartment of Nephrology, Nara Medical University, Kashihara, Nara, Japan.
Yasuhiko ItoDepartment of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Aichi, Japan.
Tetsuo MinaminoDepartment of Cardiorenal and Cerebrovascular Medicine, Kagawa University, Kita-gun, Kagawa, Japan.
Osamu YamaguchiDepartment of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
Suguru YamamotoDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Niigata, Japan.
Hirotaka KomabaDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Kengo FuruichiDepartment of Nephrology, Kanazawa Medical University School of Medicine, Kahoku, Ishikawa, Japan.
Kei FukamiDivision of Nephrology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Shin-Ichi ArakiDepartment of Nephrology, School of Medicine, Wakayama Medical University, Wakayama, Wakayama, Japan.
Takao MasakiDepartment of Nephrology, Hiroshima University Hospital, Hiroshima, Hiroshima, Japan.
Naotake TsuboiDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Hitoshi YokoyamaDepartment of Nephrology, Kanazawa Medical University School of Medicine, Kahoku, Ishikawa, Japan.
Akira ShimizuDepartment of Analytic Human Pathology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Tetsuo UshikuDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Shoichi MaruyamaDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Motoko YanagitaDepartment of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Kyoto, Japan.
Masaomi NangakuDivision of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Ryohei YamamotoHealth and Counseling Center, The University of Osaka, Suita, Osaka, Japan.
Kazunori InoueDepartment of Nephrology, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
Yoshitaka IsakaDepartment of Nephrology, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.

Funding

Health Labour Sciences Research Grant K23FC1048aJapan Agency for Medical Research and Development J240705006Japan Society for the Promotion of Science 19K0872, 20K17280, 21H02935Wellcome Trust FC001048
6 · The paper itself

Abstract

Artificial intelligence for rare pathological lesion detection faces dual challenges: expert annotation scarcity and domain shifts across institutions. Using multi-institutional kidney biopsies from 22 hospitals with 3 scanner types (NDPI, VSI, SVS), we demonstrate that model performance decreases dramatically across domains, with up to 70.3% reduction in detection precision for rare lesions such as crescents and segmental sclerosis (comprising only 2-3% of annotations). We present an approach integrating semi-supervised learning with residual CycleGAN-based domain adaptation, reducing mean Fréchet inception distance between institutions from 55.9 to 20.2 while preserving diagnostic morphology. We identified context-dependent optimal strategies: semi-supervised learning with 50% confidence threshold excelled in same-hospital scenarios (15.2-17.7% improvement for rare lesions), while our combined GAN-Semi-Supervised approach demonstrated superior performance in cross-scanner scenarios between NDPI and VSI formats (up to 63.4% improvement for crescents). This methodology enables robust performance across diverse healthcare settings with minimal expert annotation.

Identifiers

PMID41276625
PMCPMC12722389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.